By 2040, open-angle glaucoma is expected to affect more than 111 million patients per year worldwide—a number that may, in fact, be an underestimate due to the known underdiagnosis of the disease.1 In the United States, attrition rates in the ranks of ophthalmology mean that optometrists will need to continue stepping up to provide care for these glaucoma patients.
With this in mind, we have compiled The Optometrist's Guide to Glaucoma Management, an eBook containing the latest research insights, clinical pearls, and real-world commentary from leading glaucoma-focused optometrists.
You’ll find information on how to manage glaucoma and ocular hypertension patients, case reports on the principles of disease detection and grading, treatment options, guidance about surgical intervention, and co-management best practices.
Download the eBook!
📖
The Optometrist's Guide to Glaucoma Management
With case reports and clinical pearls, this eBook was designed and written to inform optometrists on updates in the diagnosis, grading, and management of glaucoma.
You’ll get 35+ images, 20+ pages, 4 case reports, and more:
- A refresher on glaucoma pathogenesis
- Importance of setting an appropriate target intraocular pressure (IOP)
- Diagnosing and detecting glaucoma
- Determining glaucoma severity
- Cost barrier and coverage conversations
- Glaucoma and ocular surface disease
- Co-managing glaucoma patients with ophthalmology
- Managing a complex glaucoma case
- Tips, tricks, and clinical pearls
Breaking down the Optometrist’s Guide to Glaucoma Management
The eBook begins with an overview of the pathogenesis of glaucoma, including the role of nitric oxide and its impact on IOP. While glaucoma’s etiology is multifactorial and not fully understood, the most effective treatment options focus on lowering IOP, traditionally determined by the ratio of aqueous humor production to aqueous outflow.
Jessica Steen, OD, FAAO, Diplo ABO, will walk us through disease diagnostics and detection, spotlighting the role of patient history and baseline measurements in crafting individualized target pressure ranges and treatment plans.
Michael Chaglasian, OD, FAAO, covers the current best practices for glaucoma staging established by the American Glaucoma Society, including mild, moderate, and severe-stage glaucoma. Dr. Chaglasian further explores new research on the growing place of OCT in glaucoma staging and the increase in accuracy that may come with a new staging system in the near future.
In the case reports, Justin Schweitzer, OD, FAAO, explores a challenging case where moderate glaucoma meets ocular surface disease and the balance that must be struck when choosing an effective—but non-damaging—treatment option.
Katherine Rachon, OD, FAAO, Dipl ABO, describes a memorable co-managed case of moderate open-angle glaucoma OD and severe open-angle glaucoma OS and the success she and the co-managing ophthalmologist found through quick action and clear communication. Additionally, Dr. Rachon offers some helpful tips to foster collaborative relationships.
Finally, Carolyn Majcher, OD, FAAO, presents a thoroughly illustrated case of neovascular glaucoma, walking us through the disease progression with imaging taken over the course of nearly a year.
